Navigation Links
Novavax Announces Publication of a Pre-clinical Study with its Pandemic 2009 H1N1 Influenza Virus-Like Particle (VLP) Vaccine
Date:5/13/2010

ROCKVILLE, Md., May 13 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announces the first report of a vaccine protecting ferrets against the 2009 pandemic H1N1 virus has been published in the journal Vaccine May 12, 2010 online issue.  Scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, co-authored the scientific report.  

Novavax produced a 2009 H1N1 influenza VLP vaccine and delivered it to the CDC in less than four (4) weeks following the April 24, 2009 announcement of the strain of the H1N1 influenza for vaccines.  CDC scientists immunized ferrets with 3.75, 7.5, or 15.0 mcg dose of 2009 H1N1 influenza VLP vaccine or a placebo then boosted with a second dose after three (3) weeks. The H1N1 influenza VLP vaccine was highly immunogenic and all vaccinated animals, even in the lowest 3.75 mcg dose group, developed hemagglutination inhibition (HI) antibody titers of 1:40 or higher, which is considered a protective level of immunity. Vaccinated animals were challenged with nasal exposure of live H1N1 influenza virus isolated. Three (3) days post challenge, animals immunized with the 15 mcg dose of the H1N1 influenza VLP vaccine had no detectable virus recovered in nasal washes and showed no signs of disease. In contrast, control animals that received no vaccine were not protected from virus replication and became ill.

Dr. Rahul Singhvi, President and CEO of Novavax, stated: "This study demonstrated in real time the ability of our influenza VLP technology to respond quickly wit
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico
2. NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
3. NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010
4. NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate
5. NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
6. NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults
7. Novavax Prices Public Offering of Common Stock
8. NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico
9. Novavax Announces Release Date of 2009 Third Quarter Financial Results and Investor Conference Call
10. NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference
11. Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... (PRWEB) September 30, 2014 Proove ... medicine, is excited to announce a new genetic test ... The Proove Pain Perception Test will provide physicians ... and why pain tolerance levels are stratified between individuals. ... identify whether a person has a genetic predisposition that ...
(Date:9/30/2014)... September 30, 2014 Fast, ... of chemistry in documents ChemAxon ... and consulting services for life science research, launches ... generate Markush structures from documents. Markush ... property, however generating and understanding Markush structures is ...
(Date:9/30/2014)... 30, 2014 BioHealth Innovation, Inc. ... biohealth innovations and increasing access to early-stage funding in ... venture capitalist, Tania Fernandez , Ph.D., has joined ... will be a member of the management team for ... to $50 million in seed and early-stage equity investments ...
(Date:9/30/2014)... 2014 The custom stainless steel fabrication ... Show 2014. The Boston Area Chapter of ISPE (International ... day-long event for Wed., Oct. 1 at Gillette Stadium ... the largest in ISPE Boston’s long history, with more ... attendees expected. , HOLLOWAY AMERICA President David Simpson ...
Breaking Biology Technology:Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 3
... Dec. 9 The results of a new study on ... 30 sites around the country, will be published in the ... Salloway, MD, MS, director of the Butler Hospital Memory and ... the Warren Alpert Medical School of Brown University, says that ...
... , SAN DIEGO, Dec. 9 ... life-saving medicines specifically designed to enhance the perfusion and ... and other gas delivery, today announced that the European ... MP4CO for the treatment of sickle cell disease. This ...
... ... Platform for High Throughput and High Content Screening. , ... Basel, Switzerland and Granada, Spain (PRWEB) December 8, ... discovery and life science research, and Fundación MEDINA (Centro de Excelencia en ...
Cached Biology Technology:Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4
(Date:9/30/2014)... think of nature as something that we enjoy when we ... Or do we think of ourselves as a part of ... what about a house? , The answers to these ... our actions, our speech and in cultural artifacts. , A ... Washington, the American Indian Center of Chicago and the Menominee ...
(Date:9/30/2014)... WASHINGTON, D.C., September 30, 2014--Sea monkeys have captured the ... of their easily observable life cycle -- sold as ... and mate given little more than a tank of ... a shorter-term pattern: Like other zooplankton, brine shrimp vertically ... conditions, coming closer to the surface at night and ...
(Date:9/30/2014)... engineers, led by Clemson University associate professor Brian ... from the U.S. Department of Energy,s Experimental Program ... positive impact on South Carolina in the advancement ... , "Understanding the scientific and engineering needs for ... nuclear technologies is imperative if South Carolina is ...
Breaking Biology News(10 mins):The cultural side of science communication 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Researchers get $5.25 million to advance nuclear technologies in South Carolina 2
... anywhere, a researcher at the Hebrew University of Jerusalem has ... the brain of a mammal. , Dr. Adi Mizrahi ... of Life Sciences at the Hebrew University, used mouse models ... undifferentiated cellular sphere into a rich and complex cell. This ...
... cure type 1 diabetes by allowing people to ... defective pancreas, medical researchers here have reported that they ... cord blood to produce insulin. , The researchers announced ... research, in the June 2007 issue of the medical ...
... organism that produces the world’s most lethal toxin is revealed today. ... Clostridium botulinum and less than 2 kg — the weight of ... on the planet. Very small amounts of the same toxin are ... , The genome sequence shows that C. botulinum doesn’t have subtle ...
Cached Biology News:A first -- Hebrew University scientist observes brain cell development in 'real time' 2Adult stem cells from human cord umbilical cord blood successfully engineered to make insulin 2Adult stem cells from human cord umbilical cord blood successfully engineered to make insulin 3Genome of Clostridium botulinum reveals the background to world's deadliest toxin 2Genome of Clostridium botulinum reveals the background to world's deadliest toxin 3
... Immunogen: synthetic peptide corresponding to the ... dopamine receptor, conjugated to KLH. The ... rat and mouse gene. Physical form: ... containing 0.01% sodium azide. Titertest method: ...
... The National Collection of Pathogenic ... authenticated human pathogenic viruses in ... is able to supply the ... from them, to the scientific ...
... The flexible and easy ... used to control all members ... family. It features a clear ... visual assay setup, user-friendly and ...
Roll of Mesh 5m x 25cm...
Biology Products: